Skip to main content
Screener/Healthcare/Biotechnology

BCAB — BioAtla, Inc.

NASDAQ
$1.74 (—)
$1.51
$71.50
—
—
EPS (TTM)$-41.72
P/E Ratio-0.08
Dividend Yield—
Market Cap$5.3M
Volume—
Prev Close$3.14
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$6.3M$-4.22——
Q4 '25$2.0M-$9.8M$-8.00140.3%-489.2%
Q3 '25$0-$15.8M$-13.50——
Q2 '25$0-$18.7M$-16.00——
Q1 '25$0-$15.3M$-13.00——
Q4 '24$0-$14.9M$-15.00——
Q3 '24$11.0M-$10.6M$-11.0097.9%-96.2%
Q2 '24$0-$21.1M$-22.00——
Get Your Daily Market Recap